Researchers have identified a specific hormone produced by pancreatic beta cells as a direct driver of obesity-linked ...

Experts answer four key questions based on the findings of a study that indicated that low-dose oral lithium could slow ...

Rendering a drug effective or ineffective in a flash at the appropriate location—this is the focus of research in photopharmacology. The goal is to develop drugs that can be switched on and off with ...

Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics ...

Endogenex today announced new findings supporting its technology for improving outcomes in individuals with type 2 diabetes.

Adding a fourth oral antidiabetic drug to a triple regimen beats metformin dose escalation for achieving glycemic control.

New UC Riverside-led research suggests Alzheimer's arises not simply from plaques forming in the brain, as is widely believed, but from one protein ...

New UC Riverside-led research suggests Alzheimer’s arises not simply from plaques forming in the brain, as is widely believed, but from one protein interfering with the normal job of another ...

For years, people with prediabetes have been told the same thing: lose weight or risk developing diabetes. But new research flips that idea on its head, showing that blood sugar can return to normal ...

Aspen Neuroscience, a clinical-stage regenerative medicine company developing autologous induced-pluripotent stem cell (iPSC) ...

Are you getting enough Vitamin K? Experts reveal why this essential nutrient is the key to preventing wrinkles, brittle bones ...

The Citizens Life Sciences Conference 2026 March 11, 2026 1:40 PM EDTCompany ParticipantsSteven Harr - President, CEO ...